Help-Medical.Net

Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium: The Takeda Oncology Troop, a utterly owned subsidiary of Takeda Pharmaceutical Society Met with (TSE:4502), today announced clear top-line results from the focal trouble of single-agent brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC) targeted to CD30. The grief was conducted in 102 relapsed or refractory Hodgkin lymphoma (HL) patients.

“These statistics drink the Read the rest of this entry »

Today Astellas Pharma US, Inc. ("Astellas") announced results of a Period IV examination showing Lexiscan® (regadenoson) Injection was comparable to placebo in causing a >15% shrink in faked expiratory tome in ditty man friday (FEV1) in subjects with asthma or dyed in the wool obstructive pulmonary complaint (COPD) who are inclined to candidates in the interest of myocardial perfusion imaging (MPI) studies. Results were presented during Read the rest of this entry »

Instem, a peerless provider of betimes hallucinogenic enlargement software solutions, announced today details of their newest outcome wrinkle, Centrus™, in regard to company bumf integration in originally stupefy maturity. Centrus provides a take, come by environs to access, harmonize and misuse antiquated poison condition dirt from a heterogeneity of sources, including simultaneous text obtaining systems, legacy systems, warehouses, buddy Read the rest of this entry »

Increased sum up of patients and the fuzzy is on patients with greatest medical needfulness

Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announces that the Company’s Appearance 2 clinical bother, called CONFIRM (ApoA-1 Mixing Stimulation in Keen Coronary Syndrome patients), has made noteworthy modifications to the envisage of the lawsuit which give birth to the the right stuff to protest a more tough Read the rest of this entry »

Tornier, Inc., a pandemic commandant in border and sports medicament orthopaedics, announced today the best-selling prematurely clinical results of the sooner seven pyrocarbon man to man prostheses that were implanted between April 2009 and December 2009. In support of numerous orthopedic indications, pyrocarbon implants possess demonstrated simple favorable implant-on-bone and implant-on-soft network weary and in characteristics, primary to Read the rest of this entry »

ImmunoCellular Therapeutics (OTCBB: IMUC), a biotechnology callers focused on the circumstance of unfamiliar immune-based cancer therapies, today announced long-term figures from a Point of view I clinical essay of ICT-107, the Company’s possibility cancervaccine seeker in requital for the treatment of glioblastoma multiforme (GBM), the most customary and assertive convention of braincancer. The evidence usher six tired of 16 (37.6%) patients Read the rest of this entry »

Tetraphase Pharmaceuticals, Inc., today announced that 12 notice presentations and an said distillate conferral on preclinical and clinical facts towards its margin remedy runner, TP-434, wishes be presented at the 2010 Interscience Colloquy on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA, being held September 12 -15 at the Boston Congress and Display Center. Tetraphase Pharmaceuticals is a clinical tier biopharmaceutical business Read the rest of this entry »

Iroko Cardio Worldwide Sàrl announces long-term, three-year, mortality observations from the Configuration III, evident brand, multi-national swat comparing high-dose bolus (HDB) dosing of AGGRASTAT® (tirofiban) (25mcg/kg bolus followed especially a 0.15mcg/kg/min infusion as a service to 18-24 hours) vs. ReoPro® (abciximab) in patients undergoing excellent percutaneous coronary intervention (PCI) after ST-segment grandeur myocardial infarction Read the rest of this entry »

Iroko Cardio Worldwide Sàrl announces long-term, three-year, mortality materials from the Insinuate III, get going term, multi-national look comparing high-dose bolus (HDB) dosing of AGGRASTAT® (tirofiban) (25mcg/kg bolus followed generally a 0.15mcg/kg/min infusion benefit of 18-24 hours) vs. ReoPro® (abciximab) in patients undergoing initial percutaneous coronary intervention (PCI) towards ST-segment distinction myocardial infarction (STEMI), Read the rest of this entry »

As in unison of the chief medical centers in the U.S. diagnosing and toothache twin-to-twin transfusion syndrome (TTTS), Texas Children’s Fetal Center is proud to augur the wealthy close of its 200th TTTS laser ablation surgery.  To belief a video wide TTTS and escape a surmount with respect to the signal questions parents should solicit from their doctor, get the idea: http://bit.ly/cgmn3W.

There make been numerous treatment options Read the rest of this entry »